LNC vs REPL · P/E 4.9, $5.94B cap vs $825.7M cap
Lincoln National Corporation (LNC) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
LNC does not have a complete income-statement cache yet.
REPL does not have a complete income-statement cache yet.
LNC currently screens at market cap $5.94B and trailing P/E 4.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the LNC and REPL stock pages for the full models.
Not investment advice.